How DCT Technology Partnerships a Better Patient Journey, Diversity, and Adherence

Client login

Home / Knowledge Centre /

Clinical Technologies / How DCT Technology Partnerships a Better Patient Journey, Diversity, and Adherence

Webinar

Back

How DCT Technology Partnerships a Better Patient Journey, Diversity, and Adherence

Almac’s Mike Hutton joined AARDEX Group’s Bernard Vrijens and THREAD’s Claire Sears to share their thoughts on innovative clinical trial solutions that are just as valuable today.

Watch the webinar recording to learn how DCTs can enable sponsors to achieve clinically meaningful data while also putting the patient experience at the forefront of clinical research.

View Resource

Our Expert

Mike Hutton, Head of Strategic Partnerships and Alliances, Almac Clinical Technologies

Almac Clinical Technologies

Almac Clinical Technologies is here to help the biopharmaceutical industry bring new therapies to those in need by empowering clinical trial sponsors to proactively manage sites, patients, and clinical trial supplies through our industry-leading Interactive Response Technology (IRT) and expert consultancy.

Almac Clinical Technologies is uniquely positioned to unlock new efficiencies in the clinical supply chain and to help achieve greater predictability in your projects and programs.

Our professionals are dedicated to delivering high-quality Interactive Response Technology (IRT) solutions, dependable professional services, and reliable customer service. Our expertise, energy, and commitment have earned us a reputation as a trusted ally in the drug development process.

Learn More

Related Resources

Blog

What is IRT and How Does it Impact Clinical Trials?

Webinar

Is Your IRT Ready to Support Direct-to-Patient Shipments?

Stay up-to-date with the latest from Almac

Join our mailing list

This website uses cookies. By continuing to browse the site, you are agreeing to our use of cookies

Please complete this form to view the Webinar

What is IRT and How Does it Impact Clinical Trials?

Is Your IRT Ready to Support Direct-to-Patient Shipments?